wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

Drug Pricing, Marketing and Pharmaceutical Regulations

Total questions: 18

Worksheet time: 9mins

Name
Class
Date
1.

What are the two main FDA acts for controlling pharmaceuticals?

a)

Food and Drug Cosmetic Act, 1938 and Public Health Service Act, 1944

b)

Drug Marketing Act, 1962 and Drug Pricing Act, 1976

c)

Pharmaceutical Regulation Act, 1980 and Drug Distribution Act, 1990

d)

Drug Development Act, 2000 and Drug Consumption Act, 2010

2.

What is the purpose of Direct-to-Consumer (DTC) drug advertising?

a)

To provide relevant information about new drugs to patients

b)

To increase drug prices and promote medicalization

c)

To improve patient compliance and communication

d)

To reduce patient adherence and increase healthcare costs

3.

What are Intellectual Property Rights (IPRs)?

a)

Laws and regulations to protect the ideas and products of innovators

b)

Exclusive marketing rights granted by the FDA upon drug approval

c)

Patents granted by the US Patents & Trademark Office

d)

Regulations for drug distribution and consumption

4.

What factors contribute to the cost of a drug?

a)

Drug production costs, development costs, and marketing costs

b)

Negotiated reimbursement by payer and wholesaler margin

c)

Retailer margin and individual health insurance policy

d)

All of the above

5.

Emma is prescribed a medication by her doctor. She notices that the generic version of the drug is cheaper than the brand-name alternative. Why do generic drugs typically cost less than brand-name alternatives?

a)

They have lower production costs.

b)

They have shorter patent protection.

c)

They have lower marketing costs.

d)

All of the above.

6.

Charlotte, Evelyn, and Emma are discussing the pharmaceutical industry. They want to know the difference between patent protection and data exclusivity. Can you help them?

a)

Patent protection grants exclusive rights to an invention, while data exclusivity grants exclusive marketing rights to a drug.

b)

Patent protection is granted by the FDA, while data exclusivity is granted by the US Patents & Trademark Office.

c)

Patent protection lasts for 20 years, while data exclusivity lasts for 5 years.

d)

Patent protection applies to small molecules, while data exclusivity applies to biologics.

7.

Which act regulates the pricing of small molecule drugs?

a)

Hatch Waxman Act

b)

Patient Protection and Affordable Care Act

c)

Biologic Price Competition and Innovation Act

d)

Drug Price Competition and Patent Term Restoration Act

8.

What is the phenomenon called 'Evergreening'?

a)

Obtaining multiple patents to extend monopoly privileges

b)

The marketing strategy for promoting a new drug

c)

The process of drug development and regulation

d)

The pricing strategy for brand name drugs

9.

What is the purpose of physician education in pharmaceutical marketing?

a)

To provide relevant information about new drugs to physicians

b)

To improve patient compliance and communication

c)

To increase drug prices and promote medicalization

d)

To reduce patient adherence and increase healthcare costs

10.

What are the main effects of Intellectual Property Rights (IPRs) on the pharmaceutical drug market?

a)

Provide incentives to innovate and develop new drugs, and provide limited-time market monopoly

b)

Increase drug prices and promote medicalization

c)

Improve patient compliance and communication

d)

Reduce patient adherence and increase healthcare costs

11.

What is the purpose of the Hatch-Waxman Act?

a)

To regulate the pricing of small molecule drugs

b)

To grant exclusive marketing rights to a drug

c)

To promote medicalization and increase drug prices

d)

To improve patient compliance and communication

12.

What are the main effects of Intellectual Property Rights (IPRs) on the pharmaceutical industry?

a)

Provide incentive to innovate and develop new drugs, and provide limited time market monopoly

b)

Increase drug prices and promote medicalization

c)

Improve patient compliance and communication

d)

Reduce patient adherence and increase healthcare costs

13.

What is the purpose of physician education in pharmaceutical marketing?

a)

To provide relevant information about new drugs to physicians.

b)

To improve patient compliance and communication.

c)

To increase drug prices and promote medicalization.

d)

To reduce patient adherence and increase healthcare costs.

14.
  1. Which other country, along with the US allow for direct-to-consumer advertising of pharmaceutical products?

a)

Australia

b)

South Africa

c)

New Zealand

d)

Switzerland

15.
  1. This organization is responsible for regulating over-the-counter drug marketing. What is its name?

a)
  1. Federal Drug Administration

b)
  1. Federal Trade Commission

c)
  1. Federal Drug Advertisement

d)

Federal Marketing Commission

16.

A patient presents a new prescription for brand-name Ozempic®. After you process the prescription, the insurance claim is rejected with the message: "Tier 4 - Preferred Alternative Available. High Copay." The patient is confused because they have prescription coverage.

This formulary tiering and the preference for an alternative agent is primarily a result of negotiations and management by which entity?

a)

The Food and Drug Administration (FDA)

b)

The drug's manufacturer

c)

The patient's Pharmacy Benefit Manager (PBM)

d)

The drug wholesaler

17.

A pharmacist sees a television commercial for an over-the-counter (OTC) allergy medication. The ad claims the product is "the only 24-hour allergy medicine proven to be 100% non-drowsy." The pharmacist knows from clinical data that the active ingredient can cause drowsiness in a small percentage of patients.

Which federal agency has the primary jurisdiction to regulate this potentially misleading OTC product advertisement?

a)

The Federal Trade Commission (FTC)

b)

The Food and Drug Administration (FDA)

c)

The Drug Enforcement Administration (DEA)

d)

The Centers for Medicare & Medicaid Services (CMS)

18.

The initial patent for a blockbuster brand-name drug for diabetes, "Glucotrol XR," is expiring. To delay generic competition, the manufacturer obtains a new patent on a minor change to the tablet's coating, which they claim improves patient adherence.

This strategy of using secondary patents to prolong a drug's market exclusivity is commonly known as:

a)

Patent Extension

b)

Evergreening

c)

Data Exclusivity

d)

Co-branding